Weekly Digest – March 2025 Weekly Digest – March 2025 21 Mar 2025: MacroGenics pulls plug on Vobra duo ADC after seeing phase 2 prostate cancer data MacroGenics decided to halt the development of Vobramitamab duocarmazine (Vobra duo) after reviewing […]